For Stocks and ETFs only As we highlighted on our social media channels, last week most major US brokers slashed online trading commissions to zero for stock and ETF trading. That news event made Barron’s cover page this weekend. While on the surface this news should be welcomed by investors, especially those focused on trading Read more ➝
US markets reversed on Trump’s 10% tariff tweet. Time to sell?
Investors are expecting a decerease in US interest rates this month. Usually, that is bullish for markets when the indexes are near all time highs.
Bristol-Meyers Squibb broke what was strong support on another day of pharma sell off. Builders fared much better as the Fed talks reduced interest rates.
Technically, all major indexes sit around their 200dMA – which means nothing really, other than everyone is watching it. Therefore, this level becomes a psychologically important level. A retracement from these levels is basically a self-fulfilling prophecy as everyone expects a fall of some sorts from here. Investors Business Daily counts only 2 distribution days Read more ➝
Today, Citigroup reported earnings in line with analysts expectations, but warned of weakness in its fixed income business. This resonates with our own concerns for the US debt market. Both government bonds and corporate bond yields have been under pressure for months as we have seen an inversion of the yield curve in some U.S. Read more ➝
Walls needed, walls built As the old adage goes, “markets climb a wall of worry”, so in good fashion BAML tapped into its inner Trump in its weekly market review to make certain sure that investors have a wall! While the US Federal Reserve tries to atleast stabilize its debt to GDP ratio – something Read more ➝
Last week the US market showed some signs of cracking its bullish momentum. The SP500 and NASDAQ fell out of their positive bullish consolidations (pennant patterns everyone is talking about) and broke back down into the August and October trading range. More bullishly, meanwhile, the DJ30 was actually holding above that trading range and continuing Read more ➝
An unlikely saviour has presented himself at a time when institutional and part-time investors dread to switch on the TV news each morning. Yes, in a sea of red ink across global markets amid almost unprecedented doom and gloom forecasts, Doctor Doom himself Nouriel Roubini has emerged as the Kon Tiki to cling to as Read more ➝